FdaApplication
ANDA 212071
Identifiers
- fda_app_no: ANDA212071
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2022-10-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CUPRIC CHLORIDE | CUPRIC CHLORIDE | EQ 0.4MG COPPER/ML | INJECTABLE;INJECTION |
1 product